Cardiac Energy Metabolism and Diastolic Dysfunction in PLWH
感染者的心脏能量代谢和舒张功能障碍
基本信息
- 批准号:10479599
- 负责人:
- 金额:$ 55.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:ATP Synthesis PathwayAccelerationActivities of Daily LivingAgeAtrial FibrillationBiological MarkersBody mass indexCardiacCardiomyopathiesCardiovascular DiseasesCardiovascular systemChronicChronic DiseaseClinicalClinical ResearchCreatine KinaseDataDevelopmentDiastolic blood pressureDiastolic heart failureDiseaseEFRACEchocardiographyEnergy MetabolismEthnic OriginExerciseExercise ToleranceFibrosisFrequenciesFunctional disorderFutureGeneral PopulationGlucose IntoleranceHIVHIV InfectionsHeartHeart DiseasesHeart failureHypertensionImpairmentIncidenceIndividualInflammationInsulin ResistanceLeftLeft Ventricular DysfunctionLinkLipidsLongitudinal StudiesMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasuresMechanicsMedicineMetabolicMetabolismMitochondriaModelingMuscleMuscle MitochondriaMyocardialMyocardiumMyopathyOutcomePatientsPerformancePersonsPilot ProjectsPopulationPrevalencePublic HealthQuestionnairesRaceReactionRecording of previous eventsRelaxationReportingResearch PersonnelResourcesRestRisk FactorsSeveritiesSkeletal MuscleSymptomsTechniquesTechnologyTestingTherapeutic InterventionTimeTissuesUnited States National Institutes of HealthVentricularViralViremiaWalkingWomancardiometabolismcohortcoronary fibrosisdesigneffective therapyexercise intoleranceexperiencefactor Afunctional declineheart metabolismimmune activationimprovedin vivoindexinginhibitorinorganic phosphateinsightmenmiddle agemortalitynovelpre-clinicalpreservationpreventive interventionprospectiverandomized trialsexsystemic inflammatory response
项目摘要
People living with HIV infection (PLWH) on ART live longer today but the incidence and prevalence of
chronic diseases is significantly higher that it is in those without HIV. As many as 50% of PLWH today have been
reported to have left ventricular diastolic dysfunction (DD), which is associated with atrial fibrillation, exercise
intolerance, and the progression to heart failure with preserved ejection fraction (HFpEF). The responsible
mechanisms for DD and its progression in contemporary PLWH populations are poorly understood but our
preliminary studies suggest that impaired cardiac energy metabolism may be a central factor linking previously
reported risk factors to DD. ATP is absolutely required for the normal myocellular relaxation and considerable
pre-clinical data and our pilot clinical studies using 31P magnetic resonance spectroscopy (MRS) suggest an
“energetic myopathy” as a basis for the DD in PLWH. In addition, inflammation is increased despite combined
ART and viral suppression in PLWH and is known to impair mitochondrial function. We propose here to examine
cardiac high energy phosphate metabolism, its causes, and its relationship to left ventricular diastolic dysfunction
(DD) and DD progression in PLWH. The central hypothesis is that cardiac mitochondrial energy metabolism is
impaired even in well-treated PLWH, and promotes the development and progression of DD in PLWH as well as
the consequences of DD including cardiac remodeling and HFpEF assessed with echocardiography, increased
circulating heart failure biomarkers, heart failure symptoms and decreased exercise performance. The specific
aims are 1) to define the scope and extent of myocardial energetic abnormalities at rest and exercise using 31P
MRS/MRI in PLWH, 2) to probe the factors underlying cardiac muscle mitochondrial and energetic abnormalities
in PLWH, including those unique to PLWH (ART history and cumulative viral history) and others more common
in PLWH (increased inflammation, immune activation, insulin resistance, cardiac fibrosis, and/or higher cardiac
muscle lipids by MRI), and 3) to determine the functional consequences of observed cardiac muscle energetic
changes in PLWH, particularly the presence and progression of DD. The studies will leverage the expertise,
resources, and established PLWH cohorts at Johns Hopkins and collect novel cardiac energetic, diastolic
function, quantitative exercise tolerance and biomarker data. The results of these studies will deliver novel
understandings of the type and extent of myocardial energetic-mitochondrial abnormalities in PLWH, the factors
prevalent in PLWH that are most closely related to impaired cardiac mitochondrial-energetic metabolism, and
the functional consequences, most importantly diastolic dysfunction. These studies, characterizing the presence
and functional consequences of what appears to be a “mitochondriopathy” of cardiac and skeletal muscle in
PLWH promise new avenues to better understand the pathophysiology of DD in PLWH and suggest the selection
and design of metabolic strategies to reduce the personal and societal impact of HIV disease-related functional
decline in this important and growing population.
如今,接受抗逆转录病毒治疗的艾滋病毒感染者 (PLWH) 的寿命更长,但艾滋病毒的发病率和患病率
如今,50% 的感染者患有慢性疾病,其患病率明显高于未感染艾滋病毒的人。
据报道患有左心室舒张功能障碍(DD),这与心房颤动、运动有关
不耐受,以及进展为射血分数保留的心力衰竭(HFpEF)。
DD 的机制及其在当代 PLWH 人群中的进展尚不清楚,但我们的研究
初步研究表明,心脏能量代谢受损可能是导致先前症状的一个核心因素。
据报道,DD 的危险因素是正常的肌细胞松弛所必需的,而且相当大。
临床前数据和我们使用 31P 磁共振波谱 (MRS) 进行的试点临床研究表明
“能量性肌病”是 PLWH DD 的基础此外,尽管合并了炎症,但炎症仍增加。
已知 PLWH 中的 ART 和病毒抑制会损害线粒体功能。
心脏高能磷酸代谢、其原因及其与左心室舒张功能障碍的关系
(DD) 和 PLWH 的 DD 进展 核心假设是心脏线粒体能量代谢是
即使在治疗良好的 PLWH 中也会受到损害,并促进 PLWH 中 DD 的发生和进展以及
DD 的后果,包括通过超声心动图评估的心脏重塑和 HFpEF,增加
循环心力衰竭生物标志物、心力衰竭症状和运动能力下降。
目的是 1) 使用 31P 定义静息和运动时心肌能量异常的范围和程度
PLWH 中的 MRS/MRI,2) 探讨心肌线粒体和能量异常的潜在因素
在 PLWH 中,包括 PLWH 特有的情况(ART 史和累积病毒史)和其他更常见的情况
PLWH(炎症增加、免疫激活、胰岛素抵抗、心脏纤维化和/或更高的心脏
通过 MRI 测量肌肉脂质),以及 3)确定观察到的心肌能量的功能后果
PLWH 的变化,特别是 DD 的存在和进展,这些研究将利用专业知识,
资源,并在约翰霍普金斯大学建立了 PLWH 队列,并收集新的心脏能量、舒张功能
这些研究的结果将提供新颖的功能、定量运动耐量和生物标志物数据。
了解 PLWH 心肌能量线粒体异常的类型和程度、影响因素
普遍存在于 PLWH 中,与心脏线粒体能量代谢受损最密切相关,并且
这些研究描述了功能后果,最重要的是舒张功能障碍。
以及心肌和骨骼肌“线粒体病”的功能后果
PLWH 承诺提供新的途径来更好地了解 PLWH 中 DD 的病理生理学并建议选择
和设计代谢策略,以减少艾滋病毒疾病相关功能对个人和社会的影响
这一重要且不断增长的人口数量的下降。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT G WEISS其他文献
ROBERT G WEISS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT G WEISS', 18)}}的其他基金
Mitochondrial energetics, exercise intolerance and fatigability in older people with HIV
老年艾滋病毒感染者的线粒体能量、运动不耐受和疲劳
- 批准号:
10367760 - 财政年份:2019
- 资助金额:
$ 55.96万 - 项目类别:
Mitochondrial energetics, exercise intolerance and fatigability in older people with HIV
老年艾滋病毒感染者的线粒体能量、运动不耐受和疲劳
- 批准号:
10601219 - 财政年份:2019
- 资助金额:
$ 55.96万 - 项目类别:
Mitochondrial energetics, exercise intolerance and fatigability in older people with HIV
老年艾滋病毒感染者的线粒体能量、运动不耐受和疲劳
- 批准号:
10380614 - 财政年份:2019
- 资助金额:
$ 55.96万 - 项目类别:
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
HIV冠状动脉粥样硬化的炎症发病机制
- 批准号:
8992823 - 财政年份:2015
- 资助金额:
$ 55.96万 - 项目类别:
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
HIV冠状动脉粥样硬化的炎症发病机制
- 批准号:
9303438 - 财政年份:2015
- 资助金额:
$ 55.96万 - 项目类别:
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
HIV冠状动脉粥样硬化的炎症发病机制
- 批准号:
8915889 - 财政年份:2014
- 资助金额:
$ 55.96万 - 项目类别:
Bioenergetics and fatigability in older individuals
老年人的生物能和疲劳性
- 批准号:
8564973 - 财政年份:2013
- 资助金额:
$ 55.96万 - 项目类别:
Bioenergetics and fatigability in older individuals
老年人的生物能和疲劳性
- 批准号:
8712312 - 财政年份:2013
- 资助金额:
$ 55.96万 - 项目类别:
相似国自然基金
基于增广拉格朗日函数的加速分裂算法及其应用研究
- 批准号:12371300
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
肠菌源性丁酸上调IL-22促进肠干细胞增殖加速放射性肠损伤修复的机制研究
- 批准号:82304065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肌红蛋白构象及其氧化还原体系探究tt-DDE加速生鲜牛肉肉色劣变的分子机制
- 批准号:32372384
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于联邦学习自动超参调整的数据流通赋能加速研究
- 批准号:62302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
M2 TAMs分泌的OGT通过促进糖酵解过程加速肝细胞癌恶性生物学行为的机制研究
- 批准号:82360529
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 55.96万 - 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:
10820331 - 财政年份:2023
- 资助金额:
$ 55.96万 - 项目类别:
Identifying and understanding the role of repeat RNAs and RAN proteins in Alzheimer's disease
识别和理解重复 RNA 和 RAN 蛋白在阿尔茨海默病中的作用
- 批准号:
10833734 - 财政年份:2023
- 资助金额:
$ 55.96万 - 项目类别:
Aortic stiffness, wave reflection, and cerebrovascular flow pulsatility: relations with brain small vessel disease and cognitive function in a middle-aged cohort
主动脉僵硬度、波反射和脑血管血流搏动:与中年队列中脑小血管疾病和认知功能的关系
- 批准号:
10662819 - 财政年份:2023
- 资助金额:
$ 55.96万 - 项目类别:
MASS: Muscle and disease in postmenopausal women
MASS:绝经后妇女的肌肉和疾病
- 批准号:
10736293 - 财政年份:2023
- 资助金额:
$ 55.96万 - 项目类别: